Dr. Reddy’s Laboratories has expanded its U.S. hospital portfolio with launch of Sugammadex Injection 200 mg/2 mL (NDC 43598-924-26) and 500 mg/5 mL (NDC 43598-925-37) Single-Dose Vial a generic equivalent of Bridion®, in the United States (US), expanding its hospital portfolio and reinforcing its commitment to improving patient access to affordable, high-quality medicines.
Sugammadex Injection is a vertically integrated product manufactured through Dr. Reddy’s global supply network. It is available from the first day of generic market entry in the United States, demonstrating the Company’s ability to reliably bring important medicines to market.
Bridion® is a registered trademark of Merck Sharp & Dohme B.V.
RDY-1026-913
